ANIX News and Press, Anixa Biosciences Inc. From 07/21/22

Anixa Biosciences Announces Notice of Allowance of Additional Patent on Breast Cancer Vaccine Technology PR Newswire SAN JOSE, Calif. , July 21, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa"), a biotechnology company focused on ...

Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology PR Newswire SAN JOSE, Calif. , June 21, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. ...

The following slide deck was published by Anixa Biosciences, Inc. in conjunction with this event. For further details see: Anixa Biosciences (ANIX) Investor Presentation - Slideshow

Anixa Biosciences has different very interesting programs ongoing, one of which is a breast cancer vaccine trial with a first partial readout at ASCO in the beginning of June. While the biotech sector has been suffering large losses over the past month, Anixa Biosciences shares have m...

Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference PR Newswire SAN JOSE, Calif. , May 5, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of...

Gainers: GTY Technology Holdings (GTYH) +114%. Vaxxinity (VAXX) +57%. Zymeworks (ZYME) +35%. Redbox Entertainment (RDBX) +33%. Finch Therapeutics Group (FNCH) +29%. Opiant Pharmaceuticals (OPNT) +29%. Puyi (PUYI) +27%. Cyngn (CYN) +24%. Clearwater (CLW) +24%. Anixa Biosciences (ANIX) +21%. Lo...

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire SAN JOSE, Calif. , April 28, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnolog...

Anixa Biosciences Inc. (NASDAQ:ANIX) traded today at a new 52-week high of $8.10. Approximately 22.9 million shares have changed hands today, as compared to an average 30-day volume of 54,000 shares. Anixa Biosciences Inc. share prices have moved between a 52-week high of $5.87 and the c...

Shares of Anixa Biosciences Inc. (NASDAQ:ANIX) traded at a new 52-week high today of $8.10. Approximately 22.9 million shares have changed hands today, as compared to an average 30-day volume of 61,000 shares. Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in h...

Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at The 4th International Workshop on CAR-T 2022 PR Newswire SAN JOSE, Calif. , April 6, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the...